April 2015, amended August 2015
World Health Organization (WHO)
Ivermectin is listed on the WHO's 'core list' of essential medicines, which is described as follows:
"The core list presents a list of minimum medicine needs for a basic health‐care system, listing the most efficacious, safe and cost–effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost‐effective treatment."
© 2025 WHO
Copyright, Licensing and Permissions
https://www.who.int/about/policies/publishing/copyright
WHO supports open access to the published output of its activities as a fundamental part of its mission and a public benefit to be encouraged wherever possible.
WHO’s open access applies to:
- all publications published by WHO CC BY-NC-SA 3.0 IGO;
- articles or chapters published in non-WHO publications that are authored or co-authored by WHO staff CC BY 3.0 IGO or CC BY-NC 3.0 IGO;
- articles or chapters published in non-WHO publications that are authored or co-authored by individuals or institutions funded in whole or in part by WHO CC BY 3.0 IGO or CC BY-NC 3.0 IGO.
document
COVID-19,ivermectin,medical treatments,pharmaceuticals